Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lantern Pharma Inc
(NQ:
LTRN
)
4.440
UNCHANGED
Streaming Delayed Price
Updated: 9:58 AM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Lantern Pharma Inc
< Previous
1
2
3
Next >
3 AI Stocks That Still Trade Under $10 Per Share
August 28, 2023
With the artificial intelligence (AI) boom ramping up, check out this short list of hot AI stocks under $10.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The 3 Most Undervalued Machine Learning Stocks to Buy Now: August 2023
August 23, 2023
Machine learning stocks still have a lot of room left to rise despite a short-term pullback in their stock prices.
Via
InvestorPlace
The 3 Most Undervalued AI Penny Stocks to Buy Now: August 2023
August 16, 2023
Not only would I take full advantage of the pullbacks in heavyweight AI stocks, I’d also take advantage of the drops in top AI penny stocks.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 AI Penny Stocks With the Potential to Make Your Financial Dreams Come True
August 09, 2023
These top three AI penny stocks offer immense upside ahead, potentially becoming future market leaders amid a $15.7 trillion projection.
Via
InvestorPlace
3 AI Stocks You’ll Regret Not Buying Soon
August 08, 2023
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.
Via
InvestorPlace
Lantern Pharma's Earnings: A Preview
March 17, 2023
Via
Benzinga
Lantern Pharma Touts Encouraging Positive Efficacy For Pancreatic Cancer Candidate
September 14, 2022
Via
Benzinga
Recap: Lantern Pharma Q2 Earnings
August 08, 2022
Lantern Pharma (NASDAQ:LTRN) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
7 AI Stocks to Buy Under $5 in August 2023
August 02, 2023
These AI stocks to buy for under $5 in August have strong potential as the sector grows throughout 2023 and beyond.
Via
InvestorPlace
3 AI Stocks to Buy Under $10 in August 2023
August 01, 2023
The bull market in artificial intelligence is just getting started, creating big opportunity for this list of AI stocks under $10.
Via
InvestorPlace
7 AI Penny Stocks that Could Hit $5 Soon
July 30, 2023
Here are seven AI penny stocks with huge potential as you look to make life-changing money from the advance of artificial intelligence.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 18, 2023
Via
Benzinga
3 Penny Stocks to Buy as the AI Sector Transforms Every Industry in 2023
May 19, 2023
These AI penny stocks could potentially offer potent long-term value at tremendously attractive prices at this time
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023
May 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 27, 2023
Via
Benzinga
7 AI Penny Stocks That Could Skyrocket in 2023
February 21, 2023
AI penny stocks represent great potential and high returns, given the fact this technology is only beginning to pervade society.
Via
InvestorPlace
Earnings Preview: Lantern Pharma
November 04, 2022
Lantern Pharma (NASDAQ:LTRN) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Lantern Pharma...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 12, 2022
Gainers Adamis Pharmaceuticals (NASDAQ:ADMP) shares moved upwards by 28.1% to $0.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.1 million.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
October 28, 2022
During Friday, 125 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 27, 2022
On Thursday, 111 stocks hit new 52-week lows.
Via
Benzinga
Treating Pediatric Cancer? How Lantern Pharma Hopes To Improve The Lives Of Pediatric Cancer Patients During Childhood Cancer Awareness Month
September 15, 2022
Every September organizations have worked to raise awareness for childhood cancer by participating in childhood cancer awareness month.
Via
Benzinga
Lantern Pharma's New Phase 2 Clinical Trial –Harmonic™ — Approved for Launch by the FDA
July 19, 2022
When most people think of lung cancer, they often picture a smoker.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 15, 2022
Via
Benzinga
Lantern Pharma Gets FDA Clearance for Mid-Stage Lung Cancer Study
July 14, 2022
The Food and Drug Administration (FDA) has announced clearance to Lantern Pharma (NASDAQ: LTRN) to proceed with Phase 2 clinical trial of its investigational new drug LP-300 in combination with...
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Lantern Pharma Q1 Earnings
May 03, 2022
Lantern Pharma (NASDAQ:LTRN) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Lantern Pharma missed estimated...
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Lantern Pharma Earnings Preview
May 02, 2022
Lantern Pharma (NASDAQ:LTRN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Lantern...
Via
Benzinga
Lantern Pharma: Q4 Earnings Insights
March 10, 2022
Lantern Pharma (NASDAQ:LTRN) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.